Ventalys Life Sciences provides custom API and CDMO solutions through a portfolio of 700+ pharmaceutical products, global operations, and more than 50 years of combined industry experience.
At Ventalys, we believe pharmaceutical supply is ultimately about people: the patients, families, physicians, pharmacists, and manufacturers who depend on critical medicines being available when they are needed. Our mission is to help make important drugs more accessible by supplying the APIs, intermediates, specialty ingredients, and custom-manufactured materials that sit at the foundation of modern medicine.
We work to serve pharmaceutical companies, distributors, CDMOs, and finished-dosage manufacturers with reliable ingredient access, practical commercial support, and documentation-led supply. Every product request represents more than a transaction; it is part of a larger supply chain that helps bring treatment options to market. Our vision is to become a trusted global partner for pharmaceutical ingredients and custom manufacturing support, built on responsiveness, quality, and long-term industry relationships.
Ventalys exists to serve the pharmaceutical industry with discipline, care, and a clear understanding of what is at stake.
Ventalys provides access to a broad portfolio of 700+ APIs, intermediates, vitamins, hormones, specialty molecules, and therapeutic ingredients across key pharmaceutical categories. We support pharmaceutical companies, distributors, CDMOs, and finished-dosage manufacturers with product availability, documentation coordination, and commercial supply support.
From formulation review to dosage development and manufacturing support, Ventalys helps customers evaluate practical CDMO pathways for commercial, clinical, and development-stage programs.
Our capabilities include support for formulations, solid and semi-solid dosages, liquids, suppositories, scale-up coordination, and documentation review.
Ventalys supports batch-level review and testing coordination where available, helping customers evaluate product identity, specifications, CoA, SDS/MSDS, impurity information, stability data, and other quality documentation before materials move through the supply chain.
For emerging drug discovery and specialty pharmaceutical companies, Ventalys supports the transition from development to commercialization by helping secure the APIs, intermediates, specialty ingredients, and manufacturing support required to move programs forward. We work with customers to review product needs, dosage pathway, documentation requirements, target market, and commercial supply options so promising programs can scale with greater confidence.
Ventalys helps pharmaceutical companies access the APIs, intermediates, specialty ingredients, and manufacturing support behind important medicines.
We support customers with 700+ product categories, global supply operations, CDMO capabilities, batch review support, and documentation-led commercial execution.
Every request is reviewed around the details that matter: molecule, grade, quantity, target market, dosage pathway, documentation, lead time, and delivery requirements.
Our purpose is to serve the pharmaceutical industry with reliable ingredient access and practical support so essential medicines can reach the people who need them.
We understand that pharmaceutical buyers need confidence that critical materials will be available when production schedules demand them. At Ventalys, we support uninterrupted supply by operating across key global markets, including Asia, the Middle East, North America, and Europe.
This international reach allows us to review supply options across multiple regions and respond quickly when timelines, documentation, or logistics requirements change. Through our Middle East operations, we can also support customers serving African markets with practical regional coordination. Our focus is to reduce supply disruption, improve delivery visibility, and help customers maintain continuity across commercial, clinical, and development-stage programs.
For Ventalys, supply chain reliability means more than moving products, it means helping customers protect production schedules, patient access, and long-term business relationships.
For smaller drug discovery and specialty pharmaceutical companies, speed matters. A promising molecule or formulation can lose momentum if the company cannot secure the right
In pharmaceutical supply, documents are not paperwork for the sake of paperwork. They are the foundation of product review, quality control, regulatory assessment, and customer
Buying APIs is not just about price and availability. For pharmaceutical companies, CDMOs, distributors, and finished-dosage manufacturers, the real question is whether the material can
When your production depends on a molecule arriving on spec, on time, and with the right paperwork, the supplier behind it matters. Ventalys supplies APIs, intermediates, and specialty pharmaceutical ingredients to pharmaceutical companies, distributors, CDMOs, and finished-dosage manufacturers, backed by documentation-led sourcing and a global supplier network.
Access to 700+ APIs, intermediates, vitamins, hormones, and specialty molecules across anti-infective, cardiovascular, oncology, CNS, and other key therapeutic categories, sourced to meet your product requirements.
Every material is supported by the quality records that matter: CoA, specifications, SDS/MSDS, impurity data, and stability information, so what you receive is traceable and ready for your program.
Operations across Asia, the Middle East, North America, and Europe let us secure supply, respond quickly when timelines shift, and help protect continuity across commercial, clinical, and development-stage programs.
Tell us the molecule, grade, and quantity you need, and our team will follow up with availability, documentation, and commercial terms.